REGENXBIO Inc.
RGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $58 | $35 | $97 | $345 |
| Short-Term Investments | $177 | $241 | $268 | $112 |
| Receivables | $22 | $26 | $30 | $32 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $22 | $33 | $21 | $29 |
| Total Curr. Assets | $278 | $335 | $416 | $519 |
| Property Plant & Equip (Net) | $171 | $193 | $207 | $192 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $10 | $39 | $201 | $392 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $8 | $10 | $11 |
| Total NC Assets | $188 | $239 | $417 | $595 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $466 | $574 | $833 | $1,114 |
| Liabilities | – | – | – | – |
| Payables | $23 | $23 | $27 | $11 |
| Short-Term Debt | $8 | $7 | $6 | $2 |
| Tax Payable | $0 | $0 | $0 | $11 |
| Deferred Revenue | $0 | $0 | $2 | $3 |
| Other Curr. Liab. | $72 | $100 | $95 | $103 |
| Total Curr. Liab. | $103 | $130 | $130 | $130 |
| LT Debt | $74 | $82 | $89 | $85 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $29 | $50 | $98 | $134 |
| Total NC Liab. | $103 | $132 | $187 | $219 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $82 | $89 | $95 | $87 |
| Total Liabilities | $206 | $262 | $317 | $350 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$932 | -$705 | -$442 | -$161 |
| AOCI | -$1 | -$4 | -$15 | -$3 |
| Other Equity | $1,193 | $1,021 | $973 | $928 |
| Total Equity | $260 | $312 | $516 | $764 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $466 | $574 | $833 | $1,114 |
| Net Debt | $25 | $55 | -$2 | -$259 |